2026 Article Archive
Protein linked to immune response against tuberculosis
Researchers at UT Southwestern Medical Center have identified a protein that helps the immune system respond to tuberculosis (TB), one of the world's leading infectious diseases.
Brain activity discovery could transform Parkinson’s treatment
Researchers at UT Southwestern Medical Center studying Parkinson’s disease have discovered a previously unrecognized sequence of abnormal activity across multiple regions of the brain, providing a new level of understanding that could improve treatment options.
New framework developed for treating liver cancer
A multidisciplinary team co-led by Amit Singal, M.D., Chief of Hepatology and Director of the Liver Tumor Program in the Division of Digestive and Liver Diseases at UT Southwestern Medical Center, has developed new treatment recommendations for liver cancer that incorporate the latest research and an expanding range of therapeutic options.
Study of living brain tissue reveals how Parkinson’s treatment works
A team co-led by UT Southwestern Medical Center researchers has identified cellular and molecular mechanisms that could explain the effects of deep brain stimulation (DBS).
New research center set to explore treatments for Alzheimer’s
Since launching in April, the North Texas Alzheimer’s Disease Research Center (NT-ADRC) based at UT Southwestern Medical Center has quickly established the foundation needed to support cutting-edge research into Alzheimer’s and related dementias.
A decade of excellence: UTSW is DFW’s top hospital for 10th year in a row
For the 10th consecutive year, UT Southwestern Medical Center has been named the No. 1 hospital in Dallas-Fort Worth by U.S. News & World Report. Additionally, UTSW ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas – in the annual U.S. News Best Hospitals list released today.
How to boost enrollment of Black, Hispanic patients in pediatric clinical trials
While Black and Hispanic families are enthusiastic about research participation, other provider and systems-focused factors may influence their involvement in pediatric oncology clinical trials, a new UT Southwestern Medical Center-led study has found.
Autoantibodies could play key role in cancer progression and prevention
Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do.
Rewriting the cancer story
Matteo Ligorio’s phone started buzzing just after 3 a.m. The texts from a hospice nurse indicated “Patient 14” had just passed away, which meant Dr. Ligorio and his team had less than four hours to honor her dying wish.
GLP-1 use rising rapidly among U.S. adolescents, young adults
Adolescents and young adults in the U.S. are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with metabolic and bariatric surgery (MBS) to manage obesity.